Sign Up
Stories
4P-Pharma Secures €15 Million Funding
Share
ADOCIA Files 2023 Registration Document
AEON Biopharma Advances Migraine Treatme...
AI-Driven Discovery and Insurance Innova...
ABIONYX Pharma Files 2023 Document
ACTICOR BIOTECH: Financial Report Postpo...
AGO Recognition Boosts BluePrint® Impact
Overview
API
4P-Pharma, a startup studio in Lille, France, secures €15 million for drug development and expansion.
Ask a question
How might 4P-Pharma's drug regeneration model impact the pharmaceutical industry?
How will 4P-Pharma's M&A and licensing-in strategies shape its competitive position?
What potential breakthroughs could arise from the development of first-in-class therapies?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage